Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis.
about
Pre- and Post-Transplant Antiviral Therapy (HBV, HCV)Systematic review: interferon-free regimens for patients with HCV-related Child C cirrhosis.Hepatitis C Virus and Liver Transplantation.Real-World Sustained Virologic Response Rates of Sofosbuvir-Containing Regimens in Patients Coinfected With Hepatitis C and HIV.Assessment of hepatocellular carcinoma risk based on peg-interferon plus ribavirin treatment experience in this new era of highly effective oral antiviral drugs.Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral-Experienced Patients With Hepatitis C.Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD.Lupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy."Hep C, where art thou": What are the remaining (fundable) questions in hepatitis C virus research?Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world studyIncidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network.Model for end-stage liver disease limbo, model for end-stage liver disease purgatory, and the dilemma of treating hepatitis C in patients awaiting liver transplantation.The dynamic landscape of liver transplant in the era of effective hepatitis C virus therapy.
P2860
Q26740319-0C57FAE6-4F5C-4C2A-8A08-FDCA2C0BC746Q30399476-D8CABD30-49AF-4D64-873A-73085F65D2D7Q33717116-0095CD22-291F-4AEA-AFFC-69F1421D7FC9Q36948099-CB79114C-93CA-4180-BA7F-5D132D27F48AQ37582545-29DE445D-1194-4549-825E-4E242AB4CBFEQ38860200-3B758564-0208-4EE7-B537-92CA541EFEF1Q40052523-14C6A328-E760-4E3D-B034-7255D15D6B67Q40404776-0AFA8D2C-99CE-413C-9D47-0F8195FFF0CDQ40536482-4F062DAD-1CBD-40CA-B7DB-EDAD5004811EQ41108422-E575E8D8-84A6-4C0B-AB70-D8C2A5636BCBQ41924669-2BAAFB1A-8B14-4F0F-A744-21F423A7F6C9Q42985980-754E76D9-BACE-49D8-B795-EB13673AC213Q45330991-1EE1FDA2-EECC-4A52-8022-B4AE6F347017
P2860
Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safety and efficacy of simepre ...... otype 1 hepatitis C cirrhosis.
@en
type
label
Safety and efficacy of simepre ...... otype 1 hepatitis C cirrhosis.
@en
prefLabel
Safety and efficacy of simepre ...... otype 1 hepatitis C cirrhosis.
@en
P2093
P2860
P356
P1476
Safety and efficacy of simepre ...... otype 1 hepatitis C cirrhosis.
@en
P2093
Adil Habib
Apurva A Modi
Hector Nazario
James F Trotter
Jean McAfee
Jeffrey Weinstein
Lauren Tujague
Maisha Barnes
Manjushree Gautam
Olga Teachenor
P2860
P304
P356
10.1002/LT.24324
P577
2015-09-03T00:00:00Z